Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | GSK3B | P49841 | 2/20 | 0.56 |
| ▸ | F3 | P13726 | 2/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.50 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Methoxycinnamic Acid SCHEMBL28937393 | 0.87 | THRB (0.73) | L3MBTL1GSK3BF3THRBATM | |
| SCHEMBL145711 | 0.86 | F3 (0.72) | GSK3BF3THRBATMMAOB | |
| SCHEMBL145712 | 0.86 | F3 (0.72) | GSK3BF3THRBATMMAOB | |
| Anisaldehyde SCHEMBL9718106 | 0.80 | ALDH1A1 (0.63) | L3MBTL1GSK3BF3THRBATM | |
| 4-Methoxy Ethyl Cinnamate SCHEMBL15190 | 0.80 | CA12 (0.71) | L3MBTL1GSK3BF3THRBATM | |
| 4-Methoxy Ethyl Cinnamate SCHEMBL434842 | 0.80 | CA12 (0.71) | L3MBTL1GSK3BF3THRBATM | |
| 4-Methoxy Ethyl Cinnamate SCHEMBL1056347 | 0.80 | CA12 (0.71) | L3MBTL1GSK3BF3THRBATM | |
| 4-Methoxy Ethyl Cinnamate SCHEMBL28937392 | 0.79 | CA12 (0.65) | L3MBTL1GSK3BF3THRBATM | |
| SCHEMBL8152426 | 0.79 | KMT2A (0.49) | L3MBTL1GSK3BF3MAOBRAB9A | |
| Toluene SCHEMBL16766953 | 0.79 | RELA (0.61) | GSK3BF3THRBATMMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2883868-B1 | CRYSTAL CONTAINING UNSATURATED CARBOXYLIC ACID AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | DAICEL CORP (JP) | 2019-10-09 | — | — | EP | disclosed |
| US-9206138-B2 | Crystal containing unsaturated carboxylic acid amide compound and method for producing same | DAICEL CORPORATION (JP) | 2015-12-08 | — | — | US | disclosed |
| US-20150299135-A1 | CRYSTAL CONTAINING UNSATURATED CARBOXYLIC ACID AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | DAICEL CORPORATION (JP) | 2015-10-22 | — | — | US | disclosed |
| EP-2883868-A1 | CRYSTAL CONTAINING UNSATURATED CARBOXYLIC ACID AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | Daicel Corporation (JP) | 2015-06-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150299135-A1 | CRYSTAL CONTAINING UNSATURATED CARBOXYLIC ACID AMIDE COMPOUND AND METHOD FOR PRODUCING SAME | ACSL1, FFAR2, FADS2 | L3MBTL1 4686/4885GSK3B 4563/4885F3 1859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.